Mr. Alicata is an associate in Lowey’s Pennsylvania office and focuses his practice on pharmaceutical antitrust litigation. Recently, Nicholas was a key member of the litigation team in Health Care Service Corp. v. Indivior Inc. et al., CL20-1474 (lead case), a matter which alleged that the makers of Suboxone committed antitrust and civil fraud violations. A five-week trial was set to begin in July of 2024, but the case was resolved on the eve of trial in one of the largest pharmaceuticals opt-out settlements to date.

Prior to joining Lowey Dannenberg, Mr. Alicata earned his J.D. from Villanova University in 2023. While in law school, he focused on healthcare law and policy while working in the Interdisciplinary Mental and Physical Health Law Clinic. Mr. Alicata also served as an intern for the Honorable Dominic Pileggi of the Pennsylvania Court of Common Pleas, as well as the Defender Association of Philadelphia.

Mr. Alicata received his undergraduate degree, cum laude, in Economics from SUNY Stony Brook in 2018 and was inducted as a member of Omicron Delta Epsilon International Economics Honor Society.